In this study, we used multidisciplinary tools to evaluate the anti-cancer potency and underlined molecular mechanism of SG, including in vitro biological anti-migration assay, molecular docking analysis for predicting the binding site of SG on EGFR, and SR-FTIR-MS for investigating the biochemical composition changes after drug treatment. Here, EGFR is linked to cancer.